"I work construction, it takes all the abuse I throw at it." ...

Compass sued Zillow in June over its listing access standards, which threatened to ban listings that were not uploaded to its platform within 24 hours of being publicly marketed. Last month, a judge ...

Property brokerage Compass on Wednesday dropped its lawsuit against Zillow, ending a legal clash over how home listings can be marketed online. For the past few years, Compass — now the largest real ...

Brokerage Compass dropped its lawsuit against Zillow after the listings giant said it would allow some pre-marketed homes on its platform, ending a multi-month fight between two real estate giants ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Compass, the largest residential real estate brokerage in the United States by sales volume, plans to lay off 110 employees in Madison in 2026. The company filed a WARN notice with the New Jersey ...

Compass’ fourth-quarter earnings call this week came with more than bottom-line metrics. The company announced a three-year partnership with Rocket and Redfin. The “strategic alliance,” as Compass ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Compass Coffee, the beleaguered D.C.-based chain, has a new owner. Elizabeth L. Gunn, a U.S. bankruptcy judge for the District of Columbia, approved the sale Thursday to London-based giant Caffè Nero, ...

The American Depositary Shares ("ADS") of the United Kingdom-based biotech Compass Pathways plc (CMPS) are soaring today, after management announced its psychedelic drug candidate COMP006 had met the ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

COMP360 shows rapid symptom improvement in depression study COMP360 may compete with J&J's Spravato if approved Compass plans FDA meeting for rolling submission Feb 17 (Reuters) - Compass Pathways ...